Topical Treatment of Psoriasis Vulgaris: The Swiss Treatment Pathway

Maul, Julia-Tatjana and Anzengruber, Florian and Conrad, Curdin and Cozzio, Antonio and Häusermann, Peter and Jalili, Ahmad and Kolios, Antonios G. A. and Laffitte, Emmanuel and Lapointe, Anne-Karine and Mainetti, Carlo and Schlapbach, Christoph and Trüeb, Ralph and Yawalkar, Nikhil and Dippel, Michaela and Navarini, Alexander A.. (2021) Topical Treatment of Psoriasis Vulgaris: The Swiss Treatment Pathway. Dermatology, 237 (2). pp. 166-178.

Full text not available from this repository.

Official URL: https://edoc.unibas.ch/80442/

Downloads: Statistics Overview


Topical treatment is crucial for the successful management of plaque psoriasis. Topicals are used either as a stand-alone therapy for mild psoriasis or else in combination with UV or systemic treatment for moderate-to-severe disease. For the choice of a suitable topical treatment, the formulation matters and not just the active substances. This expert opinion paper was developed via a non-structured consensus process by Swiss dermatologists in hospitals and private practices to illustrate the current treatment options to general practitioners and dermatologists in Switzerland. Defining treatment goals together with the patient is crucial and increases treatment adherence. Patients' personal preferences and pre-existing experiences should be considered and their satisfaction with treatment and outcome regularly assessed. During the induction phase of "classical" mild-to-moderate psoriasis, the fixed combination of topical calcipotriol (Cal) 50 μg/g and betamethasone dipropionate (BD) 0.5 mg/g once daily is frequently used for 4-8 weeks. During the maintenance phase, a twice weekly (proactive) management has proved to reduce the risk of relapse. Of the fixed combinations, Cal/BD aerosol foam is the most effective formulation. However, the individual choice of formulation should be based on a patient's preference and the location of the psoriatic plaques. Tailored recommendations are given for the topical management of specific areas (scalp, facial, intertriginous/genital, or palmoplantar lesions), certain symptoms (hyperkeratotic or hyperinflammatory forms) as well as during pregnancy or a period of breastfeeding. As concomitant basic therapy, several emollients are recommended. If topical treatment alone does not appear to be sufficient, the regimen should be escalated according to the Swiss S1-guideline for the systemic treatment of psoriasis.
Faculties and Departments:03 Faculty of Medicine > Bereich Spezialfächer (Klinik) > Dermatologie USB > Dermatologie (Navarini)
03 Faculty of Medicine > Departement Klinische Forschung > Bereich Spezialfächer (Klinik) > Dermatologie USB > Dermatologie (Navarini)
UniBasel Contributors:Navarini, Alexander
Item Type:Article, refereed
Article Subtype:Further Journal Contribution
Note:Publication type according to Uni Basel Research Database: Journal item
Identification Number:
Last Modified:31 Aug 2021 12:09
Deposited On:31 Aug 2021 12:09

Repository Staff Only: item control page